Trevi Therapeutics Initiates Pivotal Clinical Trial of Nalbuphine® ER for the Treatment of Pruritus in Prurigo Nodularis
Pruritus Relief thru Itch-Scratch Modulation (“PRISM”) Trial to enroll 240 patients and evaluate efficacy of Nalbuphine ER at 14 weeks […]